Skip to content

Public FDA record

Z-0014-2008: Brain Heart Infusion Agar labeled BHIA + Vancomycin 6 MCG/ML For Screening for Vancomycin Resistant Ent

Recall record Z-0014-2008 for Pml Microbiologicals Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0014-2008
Company in FDA record
Pml Microbiologicals Inc.
FDA classification date
Oct 10, 2007
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

Plates manufactured without vancomycin. Possibility for false resistant results.

Source facts

Action
On 4/23/07 the firm began contacting customers via fax and telephone.
Initiated
2007-04-23
Root cause
Other
Terminated
2011-06-07
Distribution
lot #229957-1: 120 plates were distributed to 9 Canadian consignees; 200 plates were shipped, quarantined, and destroyed at the Canadian distribution center. lot #229958-1: 110 plates were distributed to 9 US consignees; 210 plates were shipped, quarantined, and destroyed at the Canadian distribution center.
Recall number
Z-0014-2008
Recall status
Terminated
CDRH record ID
55355
FDA classified
2007-10-10
Recall event number
39382

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗